|
CCDC163P expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.41480005067774E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.70310029704524E-10 |
| Normal-vs-Stage2 |
5.16600000000089E-07 |
| Normal-vs-Stage3 |
1.3366999729314E-09 |
| Normal-vs-Stage4 |
5.66710012250837E-10 |
| Stage1-vs-Stage2 |
5.607400E-01 |
| Stage1-vs-Stage3 |
3.538400E-02 |
| Stage1-vs-Stage4 |
1.164350E-02 |
| Stage2-vs-Stage3 |
4.115800E-01 |
| Stage2-vs-Stage4 |
1.879210E-01 |
| Stage3-vs-Stage4 |
4.394000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.56560000519335E-08 |
| Normal-vs-AfricanAmerican |
7.01400004743391E-09 |
| Normal-vs-Asian |
2.02200478582881E-11 |
| Caucasian-vs-AfricanAmerican |
1.248360E-01 |
| Caucasian-vs-Asian |
2.017200E-03 |
| AfricanAmerican-vs-Asian |
7.703200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.82139999749253E-08 |
| Normal-vs-Female |
1.37240000475103E-08 |
| Male-vs-Female |
7.454400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.02349999586693E-08 |
| Normal-vs-Age(41-60Yrs) |
6.51709797239164E-11 |
| Normal-vs-Age(61-80Yrs) |
4.76600003906924E-09 |
| Normal-vs-Age(81-100Yrs) |
1.296000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.631200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.430200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.133180E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.536000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.786180E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.684380E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.012900E-04 |
| Classical-VS-Follicular |
2.597300E-03 |
| Classical-VS-Other |
7.717800E-01 |
| Classical-VS-Normal |
5.50269996235642E-09 |
| Tall-VS-Follicular |
2.56029999978757E-07 |
| Tall-VS-Other |
4.070800E-01 |
| Tall-VS-Normal |
2.24786855795855E-12 |
| Follicular-VS-Other |
7.648200E-01 |
| Follicular-VS-Normal |
5.755200E-04 |
| Other-VS-Normal |
6.442500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.71960001793536E-09 |
| Normal-vs-N1 |
3.52990003893439E-09 |
| N0-vs-N1 |
9.373800E-02 |
|
|
